Simultaneous Thyroid Eye Disease and IgG4-Related Orbital Disease in a Patient With Diabetes Mellitus: A Case Report.

Am J Case RepSep 21, 2026 (epub)

Brenda Hayatulhaya, Tomoyuki Kashima

✦ AI-curated · Sources linked

Case in brief

A 72-year-old man with a history of thyroid eye disease and diabetes presented with progressive proptosis and orbital swelling. After years of being denied surgery due to high risks, he underwent orbital tumor resection and decompression surgery, which alleviated his symptoms. Histopathological analysis confirmed the presence of IgG4-related orbital disease, necessitating further surgical intervention.

What made this case unusual

The simultaneous occurrence of thyroid eye disease and IgG4-related orbital disease in this patient is particularly rare and presented significant diagnostic challenges.

Diagnostic / clinical pearl

Clinicians should consider the possibility of concurrent inflammatory orbital conditions, such as IgG4-related disease, in patients with atypical presentations of thyroid eye disease.

Why it matters

Recognizing the coexistence of these conditions can influence surgical management strategies and improve patient outcomes in complex cases.

Source

Published in Am J Case Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.